-transparent.png){kind=logo}
The immunoregulatory effects of human recombinant transforming growth factor (rTGF) beta 1 and human recombinant glioblastoma-derived T cell suppressor factor (rG-TsF)/TGF beta 2 was investigated in mice infected with lymphocytic choriomeningitis virus (LCMV) or vaccinia virus. Starting on the day of infection, i.p. injections of 1 microgram/day or rTGF-beta 1 or rG-TsF/TGF-beta 2 suppressed the generation of virus specific CTL. The effect of TGF-beta on CTL (day 8) was less pronounced when TGF-beta treatment was delayed for 3 days after LCMV infection. rG-TsF/TGF-beta 2 also has an inhibiting effect on CTL-mediated disease in LCMV-infected mice: it prolonged the survival time of mice infected with LCMV and reduced the local swelling reaction after infection into the footpad. These results indicate that rTGF-beta 1 and rG-TsF/TGF-beta 2 influence T cell immune reactivity in vivo.
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
January 1988,
Cancer immunology, immunotherapy : CII,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
July 1993,
Immunology,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
October 1988,
International journal of cancer,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
August 1998,
Surgery,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
March 1999,
Zhonghua yi xue za zhi,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
October 2007,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
April 1993,
The American journal of physiology,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
February 2016,
Journal of tissue engineering and regenerative medicine,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
November 1997,
Journal of clinical immunology,
A Fontana, and
K Frei, and
S Bodmer, and
E Hofer, and
M H Schreier, and
M A Palladino, and
R M Zinkernagel
December 1992,
Lymphokine and cytokine research,
